(Q38001333)

26 August 2017

title

Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns (English)

1 reference

26 August 2017

main subject

Klebsiella pneumoniae

0 references

Enterobacteriaceae

0 references

author name string

Robert P Rapp

series ordinal

1

1 reference

26 August 2017

Carl Urban

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

5 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

32

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

399-407

1 reference

Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Penicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

The Garrod lecture. The influence of 6-aminopenicillanic acid on antibiotic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Inactivation of antibiotics and the dissemination of resistance genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Current status of carbapenem antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Klebsiella and extended spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Transferable imipenem resistance in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

80th Anniversary of the discovery of penicillin An appreciation of Sir Alexander Fleming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Penicillin: its discovery and early development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Penicillins. A current review of their clinical pharmacology and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Extended-spectrum beta-lactamases in North America, 1987-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Evolution of plasmid-coded resistance to broad-spectrum cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Updated functional classification of beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

The structure of β-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Carbapenemases: the versatile beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

What's new in antibiotic resistance? Focus on beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Multiresistant Enterobacteriaceae: new threat of an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

21 January 2018

Class A carbapenemases

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Specificity of ertapenem susceptibility screening for detection of Klebsiella pneumoniae carbapenemases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Susceptibility Profiles, Molecular Epidemiology, and Detection of KPC-Producing Escherichia coli Isolates from the New York City Vicinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Comparison of the activity of a human simulated, high-dose, prolonged infusion of meropenem against Klebsiella pneumoniae producing the KPC carbapenemase versus that against Pseudomonas aeruginosa in an in vitro pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Multidrug-resistant Gram-negative infections: what are the treatment options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Clinically significant carbapenemases: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Neurotoxicity in patients treated with intravenous polymyxin B: Two case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01035.X

10.1002/J.1875-9114.2012.01035.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference